Topiramate

NDC 42291-957 · AvKARE

Generic nameTopiramate

Dosage formCAPSULE, EXTENDED RELEASE

RouteORAL

Active ingredient(s)TOPIRAMATE

Strength100 mg/1

Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]

Marketing categoryANDA

Packages

42291-957-30 — 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-957-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

31722-181 — Topiramate, 31722-182 — Topiramate, 31722-183 — Topiramate, 31722-184 — Topiramate, 31722-547 — Topiramate, 31722-548 — Topiramate, 31722-549 — Topiramate, 31722-550 — Topiramate, 42291-955 — Topiramate, 42291-956 — Topiramate, 42291-958 — Topiramate, 43063-729 — Topiramate, 43063-734 — Topiramate, 43063-735 — Topiramate, 43063-997 — Topiramate, 43063-998 — Topiramate, 43598-624 — Phentermine and Topiramate Extended-Release, 43598-625 — Phentermine and Topiramate Extended-Release, 43598-626 — Phentermine and Topiramate Extended-Release, 43598-627 — Phentermine and Topiramate Extended-Release, +289 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.